TheraRadar
← Back
Data updated: Mar 29, 2026

AILEX PHARMS LLC

Cardiovascular
Generics

AILEX PHARMS LLC is a generic drug manufacturer focused on Cardiovascular. Key products include SODIUM PHENYLACETATE AND SODIUM BENZOATE.

2016
Since
3
Drugs
-
Trials
3
Approved (2yr)

Key Drugs

BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
bismuth subsalicylate
7 indications · 2018
SODIUM PHENYLACETATE AND SODIUM BENZOATE
sodium benzoate
3 indications · 2016

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

CROMOLYN SODIUM 2025-10-02
Manufacturing (CMC)
BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE 2025-03-31
Labeling
BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE 2024-07-08
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 100%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Novartis big-pharma
Cardiovascular
Merck big-pharma
Cardiovascular
Baxter specialty
Cardiovascular
Johnson & Johnson big-pharma
Cardiovascular
Bayer big-pharma
Cardiovascular